Clinical trials
Phase 1/2 Glioma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| BBB-Therapeutics B.V. | 1 |
| Blueprint Medicines Corporation | 1 |
| Boston Scientific Corporation | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Centre Francois Baclesse | 1 |
| Centre Leon Berard | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 17 |
| Glioblastoma | 5 |
| Brain Neoplasms | 4 |
| Central Nervous System Neoplasms | 4 |
| Medulloblastoma | 4 |
| Neuroblastoma | 4 |
| Recurrence | 4 |
| Neoplasm Metastasis | 3 |
| Rhabdomyosarcoma | 3 |
| Sarcoma, Ewing | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.